Wednesday, April 23, 2025 | 05:22 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Natco Pharma Share Price

Know More
BSENSE

842.00 10.55 (1.27%)

04:01 PM, 22-Apr-2025

839.30 9.50 (1.14%)

03:52 PM, 22-Apr-2025

BSE : 524816

NSE : NATCOPHARM

Sector : Health care

ISIN Code : INE987B01026

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 22-Apr-2025 | 04:01 PM IST

Market Cap (₹ Cr)

15,080

Traded Value (₹ Cr)

1.12

Volume (Shares)

13,259

Face Value (₹)

2

52-Week High (₹)

1,638.35

52-Week High Date

12-Sep-2024

52-Week Low (₹)

660.05

52-Week Low Date

07-Apr-2025

All Time High (₹)

1,638.35

All Time High Date

12-Sep-2024

All Time Low (₹)

1.60

All Time Low Date

17-Sep-2001

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countrie...
Read More

Natco Pharma Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Natco Pharma Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230TG1981PLC003201</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>NSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: CH VENKAT RAMESH <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: venkatramesh.ch@natcopharma.co.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: S V V N APPA RAO <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: svvn@natcopharma.co.in</div> </div> <div> <br/> Date: 09/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

More

Natco Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

15,032

EPS - TTM (₹) [C]

104.13

P/E Ratio (X) [C]

8.06

Face Value (₹) 2
Latest Dividend (%)75.00
Latest Dividend Date 18-Feb-2025
Dividend Yield (%) 1.13
Book Value Share (₹) [C]399.19
P/B Ratio (₹) [C]2.10

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Tata Equity P/E Fund - (G) 135.15 16,92,000 1.69
Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) 135.15 16,92,000 1.69
Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5%) 135.15 16,92,000 1.69
Tata Equity P/E Fund - Direct (G) 135.15 16,92,000 1.69
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt A-5%) 135.15 16,92,000 1.69
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt B-10%) 135.15 16,92,000 1.69
Tata Small Cap Fund - Regular (G) 43.86 5,49,064 0.48
Tata Small Cap Fund - Regular (IDCW) 43.86 5,49,064 0.48
Tata Small Cap Fund - Direct (G) 43.86 5,49,064 0.48
Tata Small Cap Fund - Direct (IDCW) 43.86 5,49,064 0.48

Load more

Research Reports

DateBrokerActionPrices(₹) Report
04-Oct-2024Edelweiss Securities Hold 1,440

Stock Strength

Today's Low/High (₹)

825.05

843.80

Week Low/High (₹)

778.65

843.80

Month Low/High (₹)

726.80

856.00

Year Low/High (₹)

726.80

1,639.00

All time Low/High (₹)

1.60

1,639.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week4.31%34.87%3.73%3.60%
1 Month1.20%30.75%3.50%3.50%
3 Month-33.52%-14.14%4.18%4.37%
6 Month-36.81%-18.35%-0.78%-1.25%
1 Year-16.57%7.82%8.07%8.20%
3 Year6.77%38.13%39.16%40.74%

Company Info

Company Information

Chairman & Managing Director : V C Nannapaneni

Vice Chairman & CEO : Rajeev Nannapaneni

Vice President & Director : PSRK Prasad

President & Director : D Linga Rao

Vice President & Director : Pavan Bhat

Company Sec. & Compli. Officer : Venkat Ramesh

Independent Director : A D Murthy Chavali

Independent Director : B. Lakshminarayana

Independent Director : Kantipudi Suma

Independent Director : Nitin Jain

Independent Director : Vijayabhaskar Dronadula

Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532

Email:investors@natcopharma.co.in

URL:http://www.natcopharma.co.in

FAQs about Natco Pharma Ltd

1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 842.00 at 04:01 PM IST on 22nd Apr 2025. Natco Pharma Ltd share price was up by 1.27% over the previous closing price of Rs 831.45. Natco Pharma Ltd share price trend:

  • Last 1 Month: Natco Pharma Ltd share price moved up by 1.20% on BSE.
  • Last 3 Months: Natco Pharma Ltd share price moved down by 33.52% on BSE.
  • Last 12 Months: Natco Pharma Ltd share price moved down by 16.57% on BSE.
  • Last 3 Years: Natco Pharma Ltd share price moved up by 6.77% on BSE.


2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 8.06
  • Price to book value ratio is 2.10
  • Dividend yield of 1.13
  • The EPS (trailing 12 months) of the Natco Pharma Ltd stock is Rs 104.13


3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 15,080 crore.


4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,638.35 and 52-week low share price is Rs 660.05.


5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 132.40 crore on a total income of Rs 651.10 crore for the quarter ended 2024. For the year ended 2024, Natco Pharma Ltd had posted a profit of Rs 1,388.30 crore on a total income of Rs 3,998.80 crore.


6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Concord Biotech, Alembic Pharma, Neuland Labs., Natco Pharma, Sai Life, Sanofi India, Jubilant Pharmo.


7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows:

  • Promoter holding in Natco Pharma Ltd has gone down to 49.56 per cent as of Mar 2025 from 49.71 per cent as of Jun 2024.